{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:53:00Z","timestamp":1781484780129,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Simplified diagnostic approaches are needed to eliminate hepatitis C by 2030. This prospective multicenter study evaluated dried plasma spots collected with the Cobas\u00ae Plasma Separation Card (PSC) versus conventional ethylenediaminetetraacetic acid (EDTA) plasma for hepatitis C virus (HCV) RNA detection and quantification using Cobas HCV (nucleic acid amplification test). Cobas PSCs were spotted with finger prick-collected capillary (PSC capillary) or venous (PSC venous) blood from individuals with known HCV infection status. HCV infection status was based on anti-HCV antibodies and HCV RNA in EDTA plasma. The threshold for clinical sensitivity\/specificity was 1000 IU\/mL RNA. Quantitative HCV RNA results were compared between EDTA plasma and Cobas PSC samples. Among 224 subjects, 119 had undetectable and 105 had detectable HCV RNA. Clinical sensitivity and specificity versus EDTA plasma were 100% for PSC capillary, and 97.8% and 100%, respectively, for PSC venous. HCV viral loads from PSC capillary and PSC venous were comparable with EDTA plasma. Cobas PSC combined with Cobas HCV showed good diagnostic accuracy versus EDTA plasma; quantitative HCV RNA results were comparable between the two sample types. Cobas PSC sample collection may obviate the need for venipuncture and help to broaden the reach of HCV testing in remote or under-resourced regions.<\/jats:p>","DOI":"10.1038\/s41598-026-45854-x","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:56:23Z","timestamp":1776722183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HCV RNA quantification using the Cobas Plasma Separation Card as an alternative to EDTA plasma: a prospective multicenter study"],"prefix":"10.1038","volume":"16","author":[{"given":"Ana Fuentes","family":"L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadna Rando","family":"Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Carracedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"de Salazar Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirak Zenebe","family":"Gebreab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Paraj\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit Romero","family":"Vico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Ruiz","family":"Escolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Vi\u00f1uela","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carrasco","family":"Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Buti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"45854_CR1","unstructured":"World Health Organization (WHO). Hepatitis C factsheet. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c (25 July 2025)."},{"key":"45854_CR2","doi-asserted-by":"publisher","first-page":"17006","DOI":"10.1038\/nrdp.2017.6","volume":"3","author":"MP Manns","year":"2017","unstructured":"Manns, M. P. et al. Hepatitis C virus infection. Nat. Rev. Dis. Primers. 3, 17006 (2017).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"45854_CR3","unstructured":"World Health Organization (WHO). Global hepatitis report 2024: Action for access in low- and middle-income countries. https:\/\/www.who.int\/publications\/i\/item\/9789240091672 (9 April 2024)."},{"key":"45854_CR4","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","volume":"394","author":"CW Spearman","year":"2019","unstructured":"Spearman, C. W., Dusheiko, G. M., Hellard, M. & Sonderup, M. Hepatitis C. Lancet 394, 1451\u20131466 (2019).","journal-title":"Lancet"},{"key":"45854_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/healthcare13010043","volume":"13","author":"R Venkatesh","year":"2025","unstructured":"Venkatesh, R., Huang, A. S., Gurmessa, K. & Hsu, E. B. Understanding barriers to hepatitis C antiviral treatment in low-middle-income countries. Healthcare (Basel) 13, 43 (2025).","journal-title":"Healthcare (Basel)"},{"key":"45854_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","volume":"70","author":"KA Workowski","year":"2021","unstructured":"Workowski, K. A. et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm. Rep. 70, 1\u2013187 (2021).","journal-title":"MMWR Recomm. Rep."},{"key":"45854_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad319","author":"D Bhattacharya","year":"2023","unstructured":"Bhattacharya, D. et al. Hepatitis C guidance 2023 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciad319 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"45854_CR8","unstructured":"European Association for the Study of the Liver. Clinical Practice Guidelines Panel: Chair; EASL Governing Board representative; Panel members. EASL recommendations on treatment of hepatitis C: Final update of the series. J. Hepatol. 73, 1170\u20131218 (2020)."},{"key":"45854_CR9","unstructured":"World Health Organization (WHO). Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection. https:\/\/www.who.int\/publications\/i\/item\/9789240052697 (24 June 2022)."},{"key":"45854_CR10","unstructured":"World Health Organization (WHO). Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and diagnostics. https:\/\/iris.who.int\/bitstream\/handle\/10665\/363590\/9789240052734-eng.pdf?sequence=1 (2022)."},{"key":"45854_CR11","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3390\/diagnostics11071253","volume":"11","author":"I Shahid","year":"2021","unstructured":"Shahid, I. et al. Hepatitis C diagnosis: Simplified solutions, predictive barriers, and future promises. Diagnostics (Basel). 11, 1253 (2021).","journal-title":"Diagnostics (Basel)."},{"key":"45854_CR12","unstructured":"World Health Organization (WHO). Guidelines on hepatitis B and C testing. https:\/\/www.who.int\/publications\/i\/item\/9789241549981 (16 February 2017)."},{"issue":"Suppl 2","key":"45854_CR13","doi-asserted-by":"publisher","first-page":"e25058","DOI":"10.1002\/jia2.25058","volume":"21","author":"S Fourati","year":"2018","unstructured":"Fourati, S., Feld, J. J., Chevaliez, S. & Luhmann, N. Approaches for simplified HCV diagnostic algorithms. J. Int. AIDS Soc. 21(Suppl 2), e25058 (2018).","journal-title":"J. Int. AIDS Soc."},{"key":"45854_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/diagnostics11030473","volume":"11","author":"F Vel\u00e1squez-Orozco","year":"2021","unstructured":"Vel\u00e1squez-Orozco, F. et al. Utility of the Cobas\u00ae Plasma Separation Card as a sample collection device for serological and virological diagnosis of hepatitis c virus infection. Diagnostics\u00a0(Basel) 11, 473 (2021).","journal-title":"Diagnostics"},{"key":"45854_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/hep.31060","volume":"71","author":"MG Ghany","year":"2020","unstructured":"Ghany, M. G. & Morgan, T. R. Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology 71, 686\u2013721 (2020).","journal-title":"Hepatology"},{"key":"45854_CR16","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/infdis\/jiv423","volume":"213","author":"A Soulier","year":"2016","unstructured":"Soulier, A. et al. Dried blood spots: A tool to ensure broad access to hepatitis C screening, diagnosis, and treatment monitoring. J. Infect. Dis. 213, 1087\u20131095 (2016).","journal-title":"J. Infect. Dis."},{"key":"45854_CR17","doi-asserted-by":"publisher","first-page":"w30089","DOI":"10.4414\/SMW.2021.w30089","volume":"151","author":"A Bregenzer","year":"2021","unstructured":"Bregenzer, A., Ottiger, C., Krismer, C., Sager, K. & Fux, C. A. HCV RNA quantification in capillary dried blood spots with the Xpert\u00ae HCV Viral Load test for diagnosing chronic HCV infection, monitoring treatment and detecting reinfection. Swiss Med. Wkly. 151, w30089 (2021).","journal-title":"Swiss Med. Wkly."},{"key":"45854_CR18","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/hep.23407","volume":"51","author":"E Tuaillon","year":"2010","unstructured":"Tuaillon, E. et al. Dried blood spot for hepatitis C virus serology and molecular testing. Hepatology 51, 752\u2013758 (2010).","journal-title":"Hepatology"},{"key":"45854_CR19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1186\/s12879-017-2776-z","volume":"17","author":"B Lange","year":"2017","unstructured":"Lange, B. et al. Diagnostic accuracy of detection and quantification of HBV-DNA and HCV-RNA using dried blood spot (DBS) samples\u2014A systematic review and meta-analysis. BMC Infect. Dis. 17, 693 (2017).","journal-title":"BMC Infect. Dis."},{"key":"45854_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JCM.01336-18","volume":"57","author":"S Carmona","year":"2019","unstructured":"Carmona, S., Seiverth, B., Magubane, D., Hans, L. & Hoppler, M. Separation of plasma from whole blood by use of the cobas Plasma Separation Card: A compelling alternative to dried blood spots for quantification of HIV-1 viral load. J. Clin. Microbiol. 57, 10 (2019).","journal-title":"J. Clin. Microbiol."},{"key":"45854_CR21","doi-asserted-by":"publisher","first-page":"e0232122","DOI":"10.1371\/journal.pone.0232122","volume":"15","author":"A Vubil","year":"2020","unstructured":"Vubil, A. et al. Accurate HIV viral load measurement in primary health care settings using the cobas\u00ae plasma separation card. PLoS ONE 15, e0232122 (2020).","journal-title":"PLoS ONE"},{"key":"45854_CR22","doi-asserted-by":"publisher","first-page":"113820","DOI":"10.1016\/j.jviromet.2020.113820","volume":"278","author":"EG Marins","year":"2020","unstructured":"Marins, E. G., Krey, N., Becker, A., Melzer, S. & Hoppler, M. Evaluation of the cobas\u00ae HCV test for quantifying HCV RNA in dried plasma spots collected using the cobas\u00ae Plasma Separation Card. J. Virol. Methods 278, 113820 (2020).","journal-title":"J. Virol. Methods"},{"key":"45854_CR23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/clinchem\/hvab170","volume":"68","author":"G Colucci","year":"2021","unstructured":"Colucci, G., Uceda Renteria, S., Ceriotti, F. & Lampertico, P. Clinical evaluation of Plasma Separation Cards as a tool to collect, store, and test blood samples for hepatitis B and C serological markers. Clin. Chem. 68, 214\u2013217 (2021).","journal-title":"Clin. Chem."},{"key":"45854_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/jvh.13910","volume":"31","author":"H Qureshi","year":"2024","unstructured":"Qureshi, H. et al. Context-dependent accuracy of the cobas plasma separation card for HCV RNA viral load measurement. J. Viral Hepat. 31, 156\u2013160 (2024).","journal-title":"J. Viral Hepat."},{"key":"45854_CR25","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s44197-024-00220-w","volume":"14","author":"CA Picchio","year":"2024","unstructured":"Picchio, C. A. et al. Acceptability and feasibility of the plasma separation card for an integrated model of care for hbv and hcv screening among people attending HIV clinics in Cameroon and Uganda. J. Epidemiol. Glob. Health. 14, 827\u2013838 (2024).","journal-title":"J. Epidemiol. Glob Health."},{"key":"45854_CR26","doi-asserted-by":"publisher","first-page":"114039","DOI":"10.1016\/j.jviromet.2020.114039","volume":"289","author":"J Mart\u00ednez-Campreci\u00f3s","year":"2021","unstructured":"Mart\u00ednez-Campreci\u00f3s, J. et al. Reflex viral load testing in dried blood spots generated by plasma separation card allows the screening and diagnosis of chronic viral hepatitis. J. Virol. Methods. 289, 114039 (2021).","journal-title":"J. Virol. Methods."},{"key":"45854_CR27","unstructured":"Roche Diagnostics Ltd. cobas Plasma Separation Card (PSC). https:\/\/diagnostics.roche.com\/global\/en\/products\/lab\/cobas-plasma-separation-card-rmd-4800-019.html."},{"key":"45854_CR28","doi-asserted-by":"publisher","first-page":"e0002099","DOI":"10.1371\/journal.pgph.0002099","volume":"3","author":"C Kiyaga","year":"2023","unstructured":"Kiyaga, C. et al. The plasma separation card as a novel solution for enhancing central laboratory capability for HIV-1 viral load monitoring in limited-access settings. PLOS Glob. Public Health. 3, e0002099 (2023).","journal-title":"PLOS Glob. Public Health."},{"key":"45854_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/01621459.1927.10502953","volume":"22","author":"EB Wilson","year":"1927","unstructured":"Wilson, E. B. Probable inference, the law of succession, and statistical inference. J. Am. Stat. Assoc. 22, 209\u2013212 (1927).","journal-title":"J. Am. Stat. Assoc."},{"key":"45854_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1590\/S0036-46652008000300004","volume":"50","author":"AC Castro","year":"2008","unstructured":"Castro, A. C., Borges, L. G., Souza Rda, S., Grudzinski, M. & D\u2019Azevedo, P. A. Evaluation of the human immunodeficiency virus type 1 and 2 antibodies detection in dried whole blood spots (DBS) samples. Rev. Inst. Med. Trop. Sao Paulo. 50, 151\u2013156 (2008).","journal-title":"Rev. Inst. Med. Trop. Sao Paulo."},{"key":"45854_CR31","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/jmv.22138","volume":"83","author":"LM Villar","year":"2011","unstructured":"Villar, L. M. et al. Assessment of dried blood spot samples as a simple method for detection of hepatitis B virus markers. J. Med. Virol. 83, 1522\u20131529 (2011).","journal-title":"J. Med. Virol."},{"key":"45854_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4269\/ajtmh.15-0110","volume":"93","author":"AL Dauner","year":"2015","unstructured":"Dauner, A. L. et al. Evaluation of nucleic acid stabilization products for ambient temperature shipping and storage of viral RNA and antibody in a dried whole blood format. Am. J. Trop. Med. Hyg. 93, 46\u201353 (2015).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"45854_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jcv.2015.07.303","volume":"71","author":"G McAllister","year":"2015","unstructured":"McAllister, G., Shepherd, S., Templeton, K., Aitken, C. & Gunson, R. Long term stability of HBsAg, anti-HBc and anti-HCV in dried blood spot samples and eluates. J. Clin. Virol. 71, 10\u201317 (2015).","journal-title":"J. Clin. Virol."},{"key":"45854_CR34","doi-asserted-by":"publisher","first-page":"e0231385","DOI":"10.1371\/journal.pone.0231385","volume":"15","author":"T Prinsenberg","year":"2020","unstructured":"Prinsenberg, T. et al. Dried blood spot self-sampling at home is a feasible technique for hepatitis C RNA detection. PLoS ONE 15, e0231385 (2020).","journal-title":"PLoS ONE"},{"key":"45854_CR35","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1186\/s12879-018-3529-3","volume":"18","author":"TT Nguyen","year":"2018","unstructured":"Nguyen, T. T. et al. Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam. BMC Infect. Dis. 18, 622 (2018).","journal-title":"BMC Infect. Dis."},{"key":"45854_CR36","doi-asserted-by":"publisher","first-page":"e0174823","DOI":"10.1128\/spectrum.01748-23","volume":"11","author":"P Troyano-Hern\u00e1ez","year":"2023","unstructured":"Troyano-Hern\u00e1ez, P. et al. Impact of storage time in dried blood samples (DBS) and dried plasma samples (DPS) for point-of-care hepatitis C virus (HCV) RNA quantification and HCV core antigen detection. Microbiol. Spectr. 11, e0174823 (2023).","journal-title":"Microbiol. Spectr."},{"key":"45854_CR37","doi-asserted-by":"publisher","first-page":"e0201629","DOI":"10.1371\/journal.pone.0201629","volume":"13","author":"B Neesgaard","year":"2018","unstructured":"Neesgaard, B., Ruhwald, M., Krarup, H. B. & Weis, N. Determination of anti-HCV and quantification of HCV-RNA and IP-10 from dried blood spots sent by regular mail. PLoS ONE 13, e0201629 (2018).","journal-title":"PLoS ONE"},{"key":"45854_CR38","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/cid\/ciz338","volume":"70","author":"BE Nichols","year":"2020","unstructured":"Nichols, B. E. et al. Cost and impact of dried blood spot versus plasma separation card for scale-up of viral load testing in resource-limited settings. Clin. Infect. Dis. 70, 1014\u20131020 (2020).","journal-title":"Clin. Infect. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45854-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45854-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45854-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:12:12Z","timestamp":1781482332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45854-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45854"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45854-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ARS received honoraria or research grants from Gilead; RC received research grants from Gilead; AK, ACD, and SZG are employees of Roche Diagnostics International Ltd.; NP received honoraria (speaker fees) from GlaxoSmithKline; AA received honoraria, travel grants or research grants from Gilead, Abbott Diagnostics, and Roche Diagnostics; FG received honoraria, travel grants or research grants from GSK, ViiV Healthcare, Gilead, MSD, Qiagen, Hologic and Roche Diagnostics; MB received honoraria, travel grants or research grants from AbbVie, GSK, Gilead, Janssen, Vir, and Roche Diagnostics. All other authors have no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18497"}}